Atea Pharmaceuticals Inc (AVIR)
3.71
-0.03
(-0.80%)
USD |
NASDAQ |
Apr 17, 16:00
3.73
+0.02
(+0.54%)
Pre-Market: 20:00
Atea Pharmaceuticals Market Cap: 312.25M for April 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 312.25M |
| April 16, 2024 | 314.78M |
| April 15, 2024 | 316.46M |
| April 12, 2024 | 316.46M |
| April 11, 2024 | 324.03M |
| April 10, 2024 | 317.30M |
| April 09, 2024 | 320.67M |
| April 08, 2024 | 316.46M |
| April 05, 2024 | 320.67M |
| April 04, 2024 | 324.03M |
| April 03, 2024 | 328.24M |
| April 02, 2024 | 325.72M |
| April 01, 2024 | 336.66M |
| March 28, 2024 | 340.02M |
| March 27, 2024 | 336.66M |
| March 26, 2024 | 317.30M |
| March 25, 2024 | 321.51M |
| March 22, 2024 | 341.71M |
| March 21, 2024 | 345.07M |
| March 20, 2024 | 332.45M |
| March 19, 2024 | 331.61M |
| March 18, 2024 | 336.66M |
| March 15, 2024 | 337.50M |
| March 14, 2024 | 324.03M |
| March 13, 2024 | 335.82M |
| Date | Value |
|---|---|
| March 12, 2024 | 336.66M |
| March 11, 2024 | 339.18M |
| March 08, 2024 | 336.66M |
| March 07, 2024 | 343.39M |
| March 06, 2024 | 339.18M |
| March 05, 2024 | 335.82M |
| March 04, 2024 | 340.02M |
| March 01, 2024 | 374.53M |
| February 29, 2024 | 362.75M |
| February 28, 2024 | 367.80M |
| February 27, 2024 | 383.79M |
| February 26, 2024 | 363.59M |
| February 23, 2024 | 350.43M |
| February 22, 2024 | 336.25M |
| February 21, 2024 | 351.26M |
| February 20, 2024 | 361.28M |
| February 16, 2024 | 343.75M |
| February 15, 2024 | 351.26M |
| February 14, 2024 | 335.41M |
| February 13, 2024 | 325.40M |
| February 12, 2024 | 345.42M |
| February 09, 2024 | 355.44M |
| February 08, 2024 | 355.44M |
| February 07, 2024 | 346.26M |
| February 06, 2024 | 357.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
233.62M
Minimum
Nov 22 2023
7.291B
Maximum
Feb 08 2021
1.237B
Average
532.35M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 80.97M |
| AIM ImmunoTech Inc | 23.74M |
| IGC Pharma Inc | 37.38M |
| NovaBay Pharmaceuticals Inc | 2.495M |
| Protalix BioTherapeutics Inc | 84.01M |
Market Cap Related Metrics
| PS Ratio | 0.8805 |
| Price to Book Value | 0.5624 |
| Price | 3.71 |
| Earnings Yield | -44.20% |
| Operating PE Ratio | 2.236 |
| Normalized PE Ratio | 2.728 |